Effects OF NMES With and Without Dynamic Bracing on Spasticity and Movement Quality in CP

NCT ID: NCT06303336

Last Updated: 2025-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-30

Study Completion Date

2024-05-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims at comparing Neuromuscular electrical Stimulation with and without dynamic bracing on spasticity and movement quality of lower limb in Children with Cerebral Palsy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cerebral palsy (CP) is a lifelong motor impairment caused by an early brain injury and affects 2-3 per 1,000 live births. It is a complex medical condition that negatively impacts cognition, language, sensations, movement, and gait patterns. It is normally carried out using a comprehensive approach that incorporates numerous approaches targeted at minimizing symptoms and improving functional outcomes.

NMES (Neuromuscular and Muscular Electrical Stimulation) is an instrument that provides electrical impulses to nerves, causing muscles to contract, while dynamic bracing use muscle power to pre-compress soft tissue to produce the high forces required to control specific pathological diseases.

The hip adductors, the knee flexor muscles, and the ankle and foot muscles (gastrocnemius and soleus may experience increased tone, causing the ankles to be held in a plantar-flexed (pointed downward) position) are targeted with NMES in the lower extremity to reduce the spasticity \& improve the quality of movement in CP children. Investigating how combining NMES with dynamic bracing benefits lumbar disc bulge patients adds to the growing body of evidence supporting multimodal treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diplegic Spastic Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
participants and outcome assessors will be kept blind about the intervention which the patients will be receiving

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NMES with Dynamic Bracing

The NMES targeting the hip adductors, the knee flexor muscles and the ankle \& foot muscles, along with dynamic bracing

Group Type EXPERIMENTAL

NMES with Dynamic Bracing

Intervention Type OTHER

The group will receive NMES along with dynamic bracing

NMES without Dynamic Bracing

Neuromuscular Electrical Stimulator targeting the lower extremity

Group Type EXPERIMENTAL

NMES without Dynamic Bracing

Intervention Type OTHER

The participants will receive NMES on the lower extremity

Dynamic Bracing Only

Dynamic Bracing of lower extremity

Group Type EXPERIMENTAL

Dynamic Bracing Only

Intervention Type OTHER

This group will receive dynamic bracing only on the lower limb.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NMES with Dynamic Bracing

The group will receive NMES along with dynamic bracing

Intervention Type OTHER

NMES without Dynamic Bracing

The participants will receive NMES on the lower extremity

Intervention Type OTHER

Dynamic Bracing Only

This group will receive dynamic bracing only on the lower limb.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 5 to 12 years.
* Able to walk with or without an assistive device. Classification as level I-II on the Gross Motor Functional Classification System (GMFCS).
* Able to stand with or without support for 1 minute.
* Classification as levels I-III on the Manual Ability Classification System (MACS); and the ability to follow and accept verbal instructions.
* Muscle tone scored ≥2, according to Modified Ashworth Scale.

Exclusion Criteria

* Orthopedic Surgical intervention (e.g. tendon lengthening in lower limb) within the previous 12 months
* Treatment with botulinum toxin in the calf muscles within the previous 6 months
* Presence of structural deformities at the lower limbs and trunk, or instability in the ankle joint, which could compromise the child's safety and performance of the motor task
* Severe affective or psychiatric impairments;
* Serious vision or hearing problems
* Any neurological impairment (epilepsy or any other disease that would interfere with physical activity)
Minimum Eligible Age

5 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ayesha Ashraf, MS NMPT*

Role: PRINCIPAL_INVESTIGATOR

Ripha International Univerisity

Ammara Abbas, tDPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children Hospital

Faisalābad, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/0258 Ayesha Ashraf

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.